NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (Scott+Scott), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers of Fulgent Genetics, Inc. (Fulgent) (NASDAQ: FLGT) for ...

NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (NASDAQ: FLGT) on behalf of long-term stockholders following a class action complaint that was filed against ...

PHILADELPHIA, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine (BR&B) is investigating Fulgent Genetics Inc. based on issues arising from its recent acquisitions, including the acquisition of Fulgent Pharma LLC, a wholly owned subsidiary of Fulgent Pharma Holdings, which itself is wholly-...

Piper Sandler downgraded shares of Fulgent Genetics (NASDAQ:FLGT Get Rating) from an overweight rating to a neutral rating in a research note issued to investors on Thursday morning, MarketBeat.com reports. They currently have $40.00 price target on the stock, down from their prior price ...

SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- PayPal Holdings, Inc. (NASDAQ: PYPL) Johnson Fistel, LLP is investigating potential claims on behalf of PayPal Holdings, Inc. (NASDAQ: PYPL) (PayPal or the Company) against certain of its officers and directors. If you are a current, long-term shareholder...